Suraksha Clinic and Diagnostic IPO
GMP, Subscription, Price, Dates & Financial Details
Suraksha Diagnostic Limited is a leading provider of integrated diagnostic services, offering a comprehensive range of pathology, radiology, and medical consultation services across East and North-East India, with a network covering West Bengal, Bihar, Assam, and Meghalaya. As of June 30, 2024,…
Open Date
Fri, 29 Nov 2024
Close Date
Tue, 03 Dec 2024
Price Band
₹ 420 – 441
Lot Size
34
Issue Size
₹ 846.25 Cr
Minimum Investment
₹ 14,994 (34 Shares)
Grey Market Premium Analysis
Day Wise GMP→Unofficial premium quoted in the grey market, tracked daily against the price band cap.
Grey market trading is unregulated. GMP figures are indicative only and should not be the sole basis for investment decisions - treat as a sentiment indicator, not a guarantee.
IPO Details
Suraksha Clinic and Diagnostic IPO has successfully completed its IPO process and is now listed on the NSE and BSE. According to the Red Herring Prospectus (RHP), the IPO was a book-built issue with a total issue size of ₹846.25 Crore and an offer for sale (OFS) of 1.92 Crore equity shares aggregating to ₹846.25 Crore by the existing shareholders.
The Suraksha Clinic and Diagnostic IPO remained open for subscription from November 29, 2024, to December 03, 2024. The basis of allotment was finalized on December 04, 2024, and the company's shares were listed on the NSE and BSE on December 06, 2024.
The company had fixed the price band at ₹420 to ₹441 per share, with a lot size of 34 shares. Retail investors were required to make a minimum investment of ₹14,994 (based on the upper price band) to apply for one lot.
KFin Technologies Limited served as the registrar to the issue. ICICI Securities Limited, Nuvama Wealth Management Limited, and SBI Capital Markets Limited acted as the Book Running Lead Managers (BRLMs) to the issue.
With the successful completion of the IPO process, Suraksha Diagnostic Limited is now a publicly listed company on the NSE and BSE. Investors can track the company's share price, trading performance, financial results, and corporate announcements through the stock exchanges.
Suraksha Clinic and Diagnostic IPO Timeline (Tentative)
- IPO Open Date
- Fri, 29 Nov 24
- IPO Close Date
- Tue, 03 Dec 24
- Basis of Allotment
- Wed, 04 Dec 24
- Initiation of Refunds
- Thu, 05 Dec 24
- Credit of Shares to Demat
- Thu, 05 Dec 24
- Listing Date
- Fri, 06 Dec 24 — NSE & BSE
Open Date
29 November 2024
Close Date
03 December 2024
Basis Of Allotment
04 December 2024
Listing Date
06 December 2024
IPO Subscription
Check Live Subscription →The Suraksha Clinic and Diagnostic IPO has received bids for 1,70,08,534 shares against 1,34,32,533 shares offered, resulting in an overall subscription of 1.27x. the NII category is subscribed 1.4x, Retail Investors 0.94x, and QIBs 1.74x. Within the NII category, BNII is subscribed 1.53x, while SNII is subscribed 1.16x.
QIB
1.74x
NII
1.4x
BNII
1.53x
SNII
1.16x
RII
0.94x
Total
1.27x
IPO Reservations
The Retail Individual Investor (RII) category has the highest allocation with 67,16,266 shares, representing 35% of the total issue. Qualified Institutional Buyers (QIBs) are allocated 38,37,867 shares (20%), while Non-Institutional Investors (NIIs) receive 28,78,400 shares (15%).
| Category | Shares Offered | Shares Offered % |
|---|---|---|
| Anchor Investors | 5,756,797 | 30% |
| Qualified Institutions | 3,837,867 | 20% |
| Non-Institutional | 2,878,400 | 15% |
| BNII | 1,918,934 | 10% |
| SNII | 959,466 | 5% |
| Retail Investors | 6,716,266 | 35% |
| Total | 19,189,330 | 100% |
Financials Details(₹ in Crores)
| Particular | 30 Jun 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 314.2 | 300.21 | 281.2 | 275.96 |
| Revenue | 61.85 | 222.26 | 193.69 | 225.77 |
| Profit After Tax | 7.67 | 23.13 | 6.07 | 20.82 |
| Net Worth | 187.05 | 179.41 | 155.93 | 145.84 |
| Reserve & Surplus | 176.8 | 170.88 | 147.4 | 137.31 |
| Total Borrowings | 7.57 | 8.64 | 14.01 | 19.03 |
Financials Performance
Performance Indicators
EPS Pre
Earnings per share before the IPO.
P/E Pre
IPO Offer Price ÷ EPS Pre.
EPS Post
Expected earnings per share after the IPO..
P/E (Post Issue)
IPO Offer Price ÷ EPS Post.
Suraksha Diagnostic Limited KPI Information
| Particular | KPI as of March 31, 2024. |
|---|---|
| ROE % | 14.09 |
| ROCE % | 21.46 |
| Debt / Equity | 0.2 |
| RoNW % | 14.09 |
| PbW | 13.1 |
| Pat Margin % | 10.57 |
Peers Comparison
No Peer Comparision Available
About Suraksha Diagnostic Limited
Suraksha Diagnostic Limited is a leading provider of integrated diagnostic services, offering a comprehensive range of pathology, radiology, and medical consultation services across East and North-East India, with a network covering West Bengal, Bihar, Assam, and Meghalaya. As of June 30, 2024, Suraksha operates a central reference laboratory, 8 satellite laboratories, 49 diagnostic centers, and 166 sample collection centers. It provides over 2,300 diagnostic tests, including advanced pathology and radiology tests such as CT and MRI scans.
The company follows a "hub-and-spoke" model, where its 13 hub centers perform a full range of tests, while smaller spoke centers focus on basic services. Suraksha also integrates polyclinics within its diagnostic centers, hosting 750+ specialized doctors, offering both online and offline medical consultations.
In Fiscal 2024, Suraksha derived 95% of its revenue from its core geography of Kolkata and West Bengal, with 93.83% of revenue coming from B2C services, including individual patients using diagnostic tests, home collections, and medical consultations. The company is accredited by key bodies such as the College of American Pathologists, NABL, and NABH, ensuring high standards in its operations.
Suraksha’s strong market presence, particularly in Kolkata and surrounding regions, and its reputation for quality and convenient services have earned it industry recognition, including awards for excellence in diagnostics and customer service. The company’s strategic growth is supported by its vast network, which facilitates access to diagnostic services in remote areas, and its ability to cross-sell services through integrated health offerings.
Suraksha Clinic and Diagnostic IPO Promoters
- Dr. Somnath Chatterjee
- Ritu Mittal
- Satish Kumar Verma
Promoters Holding
Holding Pre Issue
61.07%
Holding Post Issue
48.78%
Suraksha Clinic and Diagnostic IPO Objective
The Company will not receive any proceeds from the Offer for sale and all proceeds will go to the Selling Shareholders.
Suraksha Diagnostic Limited Address / Contact Details
Suraksha Diagnostic Limited
Plot No. DG-12/1, Action Area 1D,
Premises No. 02-0327, New Town,
Rajarhat, Kolkata 700 156 West Bengal
Phone: 91 33 66059750
Email: investors@surakshanet.com
Website: https://www.surakshanet.com
IPO Snapshot
Suraksha Clinic and Diagnostic IPO Lot Size
The Suraksha Clinic and Diagnostic IPO has a lot size of 34 shares. Retail investors require a minimum investment of ₹14,994 by applying for 1 lot (34 shares). The maximum application allowed for the retail category is 13 lots (442 shares), requiring an investment of ₹1,94,922.
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 34 | 14,994.00 |
| Retail (Max) | 13 | 442 | 194,922.00 |
| S-HNI (Min) | 14 | 476 | 209,916.00 |
| S-HNI (Max) | 66 | 2,244 | 989,604.00 |
| B-HNI (Min) | 67 | 2,278 | 1,004,598.00 |
Issue Reservation
- Anchor Investors — 30%
- QIB — 20%
- NII — 15%
- RII — 35%
Book Running Lead Managers
- ICICI Securities Limited
- Nuvama Wealth Management Limited
- SBI Capital Markets Limited
IPO Documents & Links
Explore More IPOs
Currently Open
Coming Up Next
Disclaimer: This data is for informational purposes only and does not constitute investment advice.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Suraksha Clinic and Diagnostic IPO?
Suraksha Clinic and Diagnostic IPO is a Book-building IPO with a total issue size of ₹846.25 crore. The Suraksha Clinic and Diagnostic IPO price band is ₹420 to 441 per share. The Suraksha Clinic and Diagnostic IPO subscription opens on Fri, Nov 29, 2024, and closes on Tue, Dec 3, 2024. The Suraksha Clinic and Diagnostic IPO will be listed on the BSE,NSE. KFin Technologies Limited is the registrar for the Suraksha Clinic and Diagnostic IPO.
When will the Suraksha Clinic and Diagnostic IPO open for subscription?
The Suraksha Clinic and Diagnostic IPO opens on Fri, Nov 29, 2024 and closes on Tue, Dec 3, 2024
What is Suraksha Clinic and Diagnostic IPO Price Band?
Suraksha Clinic and Diagnostic IPO Price Band is ₹420 to 441 per share.
What is Suraksha Clinic and Diagnostic IPO Lot Size?
Suraksha Clinic and Diagnostic IPO lot size is 34 shares, Retail investors need a minimum investment of ₹14994 based on the upper price band
What is the minimum investment for Suraksha Clinic and Diagnostic IPO?
The minimum investment for Suraksha Clinic and Diagnostic IPO is ₹14994, based on one lot of 34 shares at the upper price band of ₹441 per share.
How to apply for Suraksha Clinic and Diagnostic IPO?
Investors can apply for the Suraksha Clinic and Diagnostic IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Tue, Dec 3, 2024. The application amount remains blocked until the Suraksha Clinic and Diagnostic IPO allotment is finalized.
What is Suraksha Clinic and Diagnostic IPO Issue Size?
Suraksha Clinic and Diagnostic IPO issue size is ₹846.25 crores.
What is the Suraksha Clinic and Diagnostic IPO Allotment Date?
Suraksha Clinic and Diagnostic IPO allotment date is Wed, Dec 4, 2024.
Who is the Suraksha Clinic and Diagnostic IPO Registrar?
The registrar for Suraksha Clinic and Diagnostic IPO is KFin Technologies Limited. Investors can go to KFin Technologies Limited website to check Suraksha Clinic and Diagnostic IPO allotment status, refund processing, and other IPO-related information.
What is the Suraksha Clinic and Diagnostic IPO GMP?
The Suraksha Clinic and Diagnostic IPO GMP (Grey Market Premium) is ₹13 as of Fri, Dec 6, 2024. Based on the upper price band of ₹441 per share, the estimated Suraksha Clinic and Diagnostic IPO listing price is ₹454, indicating a potential listing gain of approximately 2.95% over the issue price.
Who is the Suraksha Clinic and Diagnostic IPO Lead Manager?
The book-running lead managers (BRLMs) for the Suraksha Clinic and Diagnostic IPO are ICICI Securities Limited, Nuvama Wealth Management Limited, and SBI Capital Markets Limited. The lead managers are responsible for managing the IPO process, including issue structuring, regulatory compliance, marketing the public issue, coordinating with investors, and ensuring a smooth listing process. For complete details, investors should refer to the Suraksha Clinic and Diagnostic IPO Red Herring Prospectus (RHP).